Research programme: apolipoprotein E4 structure correctors - Numerate
Latest Information Update: 28 Sep 2020
Price :
$50 *
At a glance
- Originator Numerate
- Developer Numerate; The J. David Gladstone Institutes
- Class Small molecules
- Mechanism of Action Apolipoprotein E modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Alzheimer's disease
Most Recent Events
- 28 Sep 2020 No recent reports of development identified for research development in Alzheimer's-disease in USA
- 02 Aug 2016 Early research in Alzheimer's disease in USA (unspecified route)